Menu Search
Equities

Elbit Medical Technologies Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
ELBDF:PNK

Elbit Medical Technologies Ltd

Actions
  • Price (USD)0.05
  • Today's Change0.00 / 0.00%
  • Shares traded47.00
  • 1 Year change--
  • Beta0.9193
Data delayed at least 15 minutes, as of Jul 17 2025 15:47 BST.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Elbit Medical Technologies Ltd is an Israel-based company engaged in the healthcare sector. It is a holding Company which was established in order to gather all of Elbit groups' bio medical and medical devices investments under one entity. Elbit Medical Technologies Ltd's medical division includes investment in InSightec Ltd that is engaged in the development, production and marketing of magnetic resonance imaging guided ultrasound equipment as well as investment in Gamida Cell Ltd that is engaged in the development of stem cell therapeutics based on its proprietary technologies for stem cell expansion as well as future regenerative cell-based medicines including heart tissue repair.

  • Revenue in ILS (TTM)2.08m
  • Net income in ILS852.81k
  • Incorporated1992
  • Employees232.00
  • Location
    Elbit Medical Technologies LtdMetsada St 9BNEI BRAK 5120109IsraelISR
  • Phone+972 36086000
  • Fax+972 36086050
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.